• Featured Product
  • KD/KO Validated

IDO1 Polyklonaler Antikörper

IDO1 Polyklonal Antikörper für IHC, WB, ELISA

Wirt / Isotyp

Kaninchen / IgG

Getestete Reaktivität

human und mehr (3)

Anwendung

WB, IHC, IF, ELISA

Konjugation

Unkonjugiert

Kat-Nr. : 13268-1-AP

Synonyme

CD107B, IDO, IDO 1, IDO1, INDO, indoleamine 2,3 dioxygenase 1, Indoleamine 2,3-dioxygenase 1, Indoleamine-pyrrole 2,3-dioxygenase



Geprüfte Anwendungen

Erfolgreiche Detektion in WBhumanes Plazenta-Gewebe, mit IFN-gamma behandelte HeLa-Zellen
Erfolgreiche Detektion in IHChumanes Tonsillitisgewebe
Hinweis: Antigendemaskierung mit TE-Puffer pH 9,0 empfohlen. (*) Wahlweise kann die Antigendemaskierung auch mit Citratpuffer pH 6,0 erfolgen.

Empfohlene Verdünnung

AnwendungVerdünnung
Western Blot (WB)WB : 1:500-1:2000
Immunhistochemie (IHC)IHC : 1:50-1:500
It is recommended that this reagent should be titrated in each testing system to obtain optimal results.
Sample-dependent, check data in validation data gallery

Produktinformation

13268-1-AP bindet in WB, IHC, IF, ELISA IDO1 und zeigt Reaktivität mit human

Getestete Reaktivität human
In Publikationen genannte Reaktivitäthuman, Hund, Maus, Ratte
Wirt / Isotyp Kaninchen / IgG
Klonalität Polyklonal
Typ Antikörper
Immunogen IDO1 fusion protein Ag3953
Vollständiger Name indoleamine 2,3-dioxygenase 1
Berechnetes Molekulargewicht 403 aa, 45 kDa
Beobachtetes Molekulargewicht 42 kDa
GenBank-ZugangsnummerBC027882
Gene symbol IDO1
Gene ID (NCBI) 3620
Konjugation Unkonjugiert
Form Liquid
Reinigungsmethode Antigen-Affinitätsreinigung
Lagerungspuffer PBS mit 0.02% Natriumazid und 50% Glycerin pH 7.3.
LagerungsbedingungenBei -20°C lagern. Nach dem Versand ein Jahr lang stabil Aliquotieren ist bei -20oC Lagerung nicht notwendig. 20ul Größen enthalten 0,1% BSA.

Hintergrundinformationen

IDO1 is the target for therapy in a range of clinical settings, including cancer, chronic infections, autoimmune and allergic syndromes, and transplantation. Elevated IDO1 expression is a hallmark of major viral infections including HIV, HBV, HCV or influenza and also of major bacteria infections, such as Tb, CAP, listeriosis and sepsis. Pathogens are able to highjack the immunosuppressive effects of IDO1 and make use of them to facilitate their own life cycle. MW of IDO1 is 40-42kd (PMID: 14502282; 17055065).

Protokolle

Produktspezifische Protokolle
WB protocol for IDO1 antibody 13268-1-APProtokoll herunterladen
IHC protocol for IDO1 antibody 13268-1-APProtokoll herunterladen
Standard-Protokolle
Klicken Sie hier, um unsere Standardprotokolle anzuzeigen

Publikationen

SpeciesApplicationTitle
humanWB

Hepatology

Indoleamine-2, 3-dioxygenase as an effector and an indicator of protective immune responses in patients with acute hepatitis B.

Authors - Sachiyo Yoshio
  • KO Validated
mouseWB

Acta Biomater

Blockage of the IDO1 pathway by charge-switchable nanoparticles amplifies immunogenic cell death for enhanced cancer immunotherapy.

Authors - Menghao Shi
mouseWB

ACS Appl Mater Interfaces

Mitigation Effects of Selenium Nanoparticles on Depression-Like Behavior Induced by Fluoride in Mice via the JAK2-STAT3 Pathway.

Authors - Jiarong Yang
humanWB

J Immunother Cancer

GCH1 induces immunosuppression through metabolic reprogramming and IDO1 upregulation in triple-negative breast cancer.

Authors - Jin-Li Wei
humanWB

J Immunother Cancer

Tryptophan potentiates CD8+ T cells against cancer cells by TRIP12 tryptophanylation and surface PD-1 downregulation.

Authors - Rui Qin
humanWB

Theranostics

Enhanced cancer therapy through synergetic photodynamic/immune checkpoint blockade mediated by a liposomal conjugate comprised of porphyrin and IDO inhibitor.

Authors - Zeqian Huang

Rezensionen

The reviews below have been submitted by verified Proteintech customers who received an incentive forproviding their feedback.


FH

Christopher (Verified Customer) (01-28-2022)

Worked well with a 1 hour incubation at room temperature.

  • Applications: Western Blot
  • Primary Antibody Dilution: 1:2000
  • Cell Tissue Type: A549
IDO1 Antibody Western Blot validation (1:2000 dilution) in A549 (Cat no:13268-1-AP)
FH

Hala (Verified Customer) (09-18-2020)

I am very satisfied of this antibody and of the interaction with your company

  • Applications: Western Blot
  • Primary Antibody Dilution: 1:1000
  • Cell Tissue Type: macrophages and hela cells
IDO1 Antibody Western Blot validation (1:1000 dilution) in macrophages and hela cells (Cat no:13268-1-AP)